Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

generic medicines

  1. Home>
  2. News>
  3. generic medicines>
  4. Page 25

How to Verify the Quality of Indian Generic Medicines: A Buyer’s Guide

  • Post published:June 6, 2026
  • Post category:Knowledge

Indian generic medicines have earned global recognition for making high-quality healthcare affordable. However, with over 10,000 manufacturers across the country, quality standards can vary. This guide explains exactly how to…

Continue Reading How to Verify the Quality of Indian Generic Medicines: A Buyer’s Guide

India’s Semaglutide Generic Boom Reshapes GLP-1 Market in 2026

  • Post published:June 5, 2026
  • Post category:News

On March 20, 2026, Novo Nordisk's patent on semaglutide expired in India, triggering one of the most significant transformations in the country's pharmaceutical history. Within weeks, more than 40 Indian…

Continue Reading India’s Semaglutide Generic Boom Reshapes GLP-1 Market in 2026

How to Choose a Reliable Indian Generic Medicine Supplier: A Complete Buyer’s Guide

  • Post published:June 4, 2026
  • Post category:Knowledge

🔬 How to Choose a Reliable Indian Generic Medicine Supplier: A Complete Buyer’s Guide India supplies approximately 20% of the world’s generic medicines by volume, exporting over USD 50 billion…

Continue Reading How to Choose a Reliable Indian Generic Medicine Supplier: A Complete Buyer’s Guide

WHO-GMP Certification for Indian Generics: What the New Schedule M Rules Mean for You

  • Post published:June 2, 2026
  • Post category:Knowledge

🔬 WHO-GMP Certification for Indian Generics: What the New Schedule M Rules Mean for You India supplies approximately 20% of the world's generic medicines by volume, making it the largest…

Continue Reading WHO-GMP Certification for Indian Generics: What the New Schedule M Rules Mean for You
  • Go to the previous page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • Go to the next page

Recent Posts

  • Understanding CDSCO’s NSQ Drug Quality Alerts: A Buyer’s Guide for 2026
    September 30, 2026/
    0 Comments
  • CDSCO’s Risk-Based Regulation Push at iPHEX 2026
    September 29, 2026/
    0 Comments
  • A Buyer’s Guide to WHO-GMP Certified Indian Generic Medicines
    September 28, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • Understanding CDSCO’s NSQ Drug Quality Alerts: A Buyer’s Guide for 2026
  • CDSCO’s Risk-Based Regulation Push at iPHEX 2026
  • A Buyer’s Guide to WHO-GMP Certified Indian Generic Medicines
  • India’s PLI Bulk Drug Push: Rs 5,210 Crore Invested by June 2026
  • CDSCO’s Digital Drug Regulatory Platform: What Buyers Should Know

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve